Delivery Order SPE2DB24D9113-SPE2DB24FEPVX

Award Date 7/31/24
Potential Completion Date 8/21/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of the pharmaceutical product "VISIONBLUE 0.06% SYRINGE 0.5ML" to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the DLA's SPE2DB indefinite delivery vehicle, valued at up to $1,634.04 through April 2024. The contract is for the delivery of VISIONBLUE 0.06% Syringe 0.5ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $3,268.08 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler in Park Ridge, Illinois. The contract is for the delivery of 0.5ML VISIONBLUE 0.06% syringes and has a completion date of May 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB prime vendor program. The $1,556.52 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML pharmaceutical products to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
This federal contract award, identified as SPE2DB20D9759|SPE2DB25FD5KH, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,691.16 firm fixed-price delivery order is for the supply of 4567359727 ! VISIONBLUE 0.06% SYRINGE 0.5ML, with a performance period through January 29, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois, is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies. The contract, valued at $1,634.04, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has no set-aside designation and is part of DMS Pharmaceutical Group's broader prime vendor contract SPE2DB, valued up to...
This federal contract award, valued at $46,246.21, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. The contract requires DMS Pharmaceutical Group to...
This federal contract award, valued at $1,454.05, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 and running through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a broad range of...
  • SPE2DB24D9113
    Indefinite Delivery Contract
  • SPE2DB24D9113-SPE2DB24FEPVX
    Delivery Order

This federal contract award, valued at $2,451.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to provide a specific pharmaceutical product, the VISIONBLUE 0.06% SYRINGE 0.5ML, to support the recurring medical supply needs of military health facilities worldwide.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the diverse medical requirements of the Department of Defense (DoD) healthcare facilities. The contract does not have a set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business has enabled the company to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 10/30/24, 9:26 AM